3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Glioblastoma
2
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Pulmonary Nodules
1
Medication Adherence
1
Margins of Excision
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Early-stage Peripheral Non-small Cell Lung Cancer
1
Dementia
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Alzheimer Disease
1
Interventions
apixaban
4
abelacimab
2
MAA868
2
isoquercitrin
1
enoxaparin sodium
1
Rosuvastatin Calcium
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Educational Status
1
Dalteparin
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pulmonary Embolism
×
Drug Delivery Systems
×
1 year
×
Clear all
No trials found.